Sign up
Log in
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of argenx SE (NASDAQ:ARGX) rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-injection in generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.

argenx shares jumped 5.1% to $573.88 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • MSP Recovery, Inc. (NASDAQ:MSPR) rose 167% to $3.43 in pre-market trading as the company announced strategic term sheet providing prospective liquidity and restructuring of existing agreements to remove corporate guaranteed debt by over $1.2 billion as well as new agreements aimed at driving future growth.
  • Sharps Technology, Inc. (NASDAQ:STSS) surged 73.6% to $0.0318 in pre-market trading after jumping 30% on Thursday.
  • Enzo Biochem, Inc. (NYSE:ENZ) gained 26.5% to $0.3300 in pre-market after dipping 22% on Thursday.
  • Actelis Networks, Inc. (NASDAQ:ASNS) rose 26.4% to $0.8198 in pre-market trading. Actelis Networks recently announced it received a new order to modernize Orange County’s traffic infrastructure.
  • Venus Concept Inc. (NASDAQ:VERO) rose 25.6% to $5.10 in pre-market trading. Venus Concept announced closing of $1.1 million registered direct offering of common stock priced at-the-market under Nasdaq rules.
  • DMC Global Inc. (NASDAQ:BOOM) gained 21.7% to $7.90 in pre-market trading.
  • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) jumped 19.1% to $5.37 in pre-market trading.
  • Certara, Inc. (NASDAQ:CERT) surged 18.1% to $12.41 in pre-market trading after gaining 8% on Thursday.
  • Simulations Plus, Inc. (NASDAQ:SLP) gained 13.7% to $29.23 in pre-market trading. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.

Losers

  • AlTi Global, Inc. (NASDAQ:ALTI) fell 57.3% to $1.20 in pre-market trading after declining around 6% on Thursday.
  • cbdMD, Inc. (NYSE:YCBD) shares tumbled 38.9% to $0.1701 in pre-market trading. CbdMD announced shareholder approval of automatic conversion of series a preferred stock and other results from annual meeting.
  • Nexa Resources S.A. (NYSE:NEXA) fell 32% to $4.01 in today's pre-market trading.
  • Organovo Holdings, Inc. (NASDAQ:ONVO) shares fell 27.1% to $1.59 in pre-market trading.
  • Palatin Technologies, Inc. (NYSE:PTN) fell 16.8% to $0.3510 in pre-market trading after the company announced it received a NYSE American notice of delisting.
  • Betterware de México, S.A.P.I. de C.V. (NYSE:BWMX) shares fell 24% to $8.21 in pre-market trading. Betterware de México will report its first quarter results after the U.S. market close on Thursday, April 24.
  • Solaris Resources Inc. (NYSE:SLSR) shares dipped 22.3% to $2.20 in pre-market trading.
  • InnovAge Holding Corp. (NASDAQ:INNV) fell 14.9% to $2.35 in pre-market trading.
  • Costamare Inc. (NYSE:CMRE) dipped 14.3% to $7.42 in pre-market trading after falling 5% on Thursday.
  • Maze Therapeutics, Inc. (NASDAQ:MAZE) declined 12.8% to $6.62 in pre-market trading after falling 5% on Thursday.

Now Read This:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.